Impact and timing of pulmonary rehabilitation in patients undergoing bronchoscopic lung volume reduction with endobronchial valves: A multicentre randomized …
MC van der Molen, R Posthuma, JE Hartman… - …, 2024 - Wiley Online Library
Abstract Background and Objective Both bronchoscopic lung volume reduction with
endobronchial valves (BLVR‐EBV) and pulmonary rehabilitation (PR) are effective …
endobronchial valves (BLVR‐EBV) and pulmonary rehabilitation (PR) are effective …
Network meta-analysis of the efficacy and safety of monoclonal antibodies and traditional conventional dichotomous agents for chronic obstructive pulmonary disease
Y Xiong, J Hu, H Tang, Z Zhao, L Liu - Frontiers in Medicine, 2024 - frontiersin.org
Introduction Monoclonal antibodies (mAbs) against cytokines and chemokines or their
receptors promise to be a potential therapeutic option to address chronic obstructive …
receptors promise to be a potential therapeutic option to address chronic obstructive …
Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview
MG Matera, B Rinaldi, C Belardo… - Expert Review of Clinical …, 2022 - Taylor & Francis
Introduction Long-acting muscarinic receptor antagonist (LAMA)/β2-agonist (LABA)
combinations represent a significant improvement in the treatment of chronic obstructive …
combinations represent a significant improvement in the treatment of chronic obstructive …
Differential Response to 12 Weeks of Once-Daily Tiotropium/Olodaterol Fixed Dose Combination in Patients with COPD: A Multidimensional Response Profiling in the …
R Posthuma, LEGW Vanfleteren, S Gaffron… - … journal of chronic …, 2023 - Taylor & Francis
Purpose Long-acting bronchodilators (LABD), in general, reduce respiratory symptoms,
improve exercise endurance time and pulmonary function in patients with chronic …
improve exercise endurance time and pulmonary function in patients with chronic …